Pujan Ajmera
ajmera-pujan.bsky.social
Pujan Ajmera
@ajmera-pujan.bsky.social
4th year Ph.D. Candidate in Theoretical and Computational Chemistry @ UCLA, Alexandrova Lab

Thinking about persistent quantum phenomena in biological systems
Reposted by Pujan Ajmera
Wrapping up this year with good food, lots of laughs, and even better company at our annual winter solstice party ✨
Wishing all our friends here on Bluesky a warm, restful, and happy holiday season!
#chemsky #compchemsky #chemchat
December 20, 2025 at 11:05 PM
Reposted by Pujan Ajmera
Vibronic coupling limits the use of high-lying electronic states in complex molecules for laser cooling
Out now in Phys. Rev. Research:

👉 doi.org/10.1103/kw2m...

#compchem #chemsky #compchemsky #quantum
doi.org
December 9, 2025 at 7:06 PM
Reposted by Pujan Ajmera
We conducted a #ChemNobel prediction poll in the group on the #NobelPrize in Chemistry Eve!

(PS: we might be a little biased 😉) #chemsky #compchem #compchemsky
October 8, 2025 at 3:14 AM
Reposted by Pujan Ajmera
✨Exciting news - the Alexandrova Group is now on Bluesky!✨

Hello, friends on #chemsky and #compchemsky. We're glad to be here! Stay tuned for the latest #compchem 💻 research and news from the lab!
October 3, 2025 at 10:45 PM
Reposted by Pujan Ajmera
ORCA 6.1 will be released tomorrow after the online event to which you are all invited! As a final appetiser, we have a sneak preview of some new methods that will be available in the new version.

#ORCA61 #ORCAqc #CompChem #QuantumChem #TheoChem #FACCTs #MPIKOFO #ChemSky #CompChemSky
June 16, 2025 at 11:03 AM
Reposted by Pujan Ajmera
shel silverstein on the LLM, 1981
June 10, 2025 at 7:34 PM
Reposted by Pujan Ajmera
🧪In a JAMA viewpoint paper, the FDA expresses its intent to use AI for first-pass reviews of drug applications to significantly increase efficiency.

This is premature and we haven't seen the evidence AI is ready for this use case.

Link to the paper: jamanetwork.com/journals/jam...

#MedSky #MLSky
F.D.A. to Use A.I. in Drug Approvals to ‘Radically Increase Efficiency’
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
www.nytimes.com
June 10, 2025 at 9:11 PM